Recordati Rare Diseases North America
Eric Hancock is a seasoned professional in the pharmaceutical industry with extensive experience in sales, education, and account management. Currently serving as the Regional Business Director for Recordati Rare Diseases Inc. since February 2020, Eric has successfully led promotional efforts for products related to Cushing’s disease and acromegaly. Previously, as a Senior Cardiopulmonary Specialist at United Therapeutics Corporation, Eric drove sales initiatives for treatments targeting pulmonary arterial hypertension. Eric's career began at Rhone-Poulenc Rorer and included significant roles at sanofi-aventis, where achievements included being recognized as Regional Manager of the Year in 2004. Eric holds a BA in Organizational Management from Alaska Pacific University.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.